Ongoing Trials
- A multicenter trial assessing the impact of Lp(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis (Lp(a)FRONTIERS CAVS) (NCT05646381)
- Assessing the impact of Lp(a) lowering with pelacarsen (YQJ330) on major cardiovascular events in patients with CVD (Lp(a)HORIZON) (NCT04023552)
